Skip to main content
. 2020 Apr 7;323(13):1277–1285. doi: 10.1001/jama.2020.1943

Table 1. Baseline Characteristics of Study Cohort.

Characteristic No. (%)
Celiac disease
(n = 49 829)
Matched comparators
(n = 246 426)
Female sex 31 086 (62.4) 154 056 (62.5)
Male sex 18 743 (37.6) 92 370 (37.5)
Age at diagnosis, y
Mean (SD) 32.2 (25.2) 31.9 (25.1)
Median (interquartile range) 28.5 (8.4-53.5) 28.0 (8.3-53.0)
Range 0.0-95.4 0.0-95.8
Age categories
<18 y 19 632 (39.4) 98 080 (39.8)
≥18-<40 y 10 913 (21.9) 54 212 (22.0)
≥40-<60 y 9946 (20.0) 49 268 (20.0)
≥60 y 9338 (18.7) 44 866 (18.2)
Country of birth
No. of participants 49 827 (100.0) 246 414 (100.0)
Nordic country 47 765 (95.9) 226 192 (91.8)
Other country 2062 (4.1) 20 222 (8.2)
Level of education
No. of participants 28 496 (57.2) 139 930 (56.8)
≤9 y 8617 (30.2) 44 048 (31.5)
10-≤12 y 11 856 (41.6) 58 570 (41.9)
>12 y 8023 (28.2) 37 312 (26.7)
Parents’ highest level of education (used when patient’s level of education is missing
No. of applicable participants 47 682 (95.7) 235 572 (95.6)
≤9 y 9798 (20.5) 50 987 (21.6)
10-≤12 y 20 090 (42.1) 99 391 (42.2)
>12 y 17 794 (37.3) 85 194 (36.2)
Start year of follow-up
1969-1989 4339 (8.7) 21 604 (8.8)
1990-1999 13 585 (27.3) 67 331 (27.3)
2000-2009 19 914 (40.0) 98 232 (39.9)
2010-2017 11 991 (24.1) 59 259 (24.0)
Disease history before start of follow-up
Type 1 diabetes 1565 (3.1) 667 (0.3)
Inflammatory bowel disease 1401 (2.8) 365 (0.1)
Autoimmune thyroid disease 1126 (2.3) 1852 (0.8)
Rheumatoid arthritis 423 (0.8) 1096 (0.4)
Deaths
Days after index date
≤30 114 (0.2) 121 (<0.1)
≤90 280 (0.6) 401 (0.2)
≤365 757 (1.5) 1599 (0.6)
All follow-up time 6596 (13.2) 28 890 (11.7)